Medical Science Liaison - Rare Diseases, Brazil (North East/Central West)

This role is considered Virtual.

Overview

The Medical Science Liaison is a field-based scientific and clinical expert that strategically supports the medical, scientific and business objectives of Alnylam’s investigational and approved therapies in Acute Hepatic Porphyrias and Primary Hyperoxaluria Type 1. It is accountable to communicate the science and clinical application of RNAi to Healthcare Practitioners (HCPs). In addition, MSLs are expected to build strong cross-functional relationships with colleagues in Medical Affairs, Clinical Research, R&D, Patient Advocacy and Commercial Operations, while maintaining full compliance with all relevant company, industry, legal, and regulatory requirements. This role reports to the Country Medical Director.

Key Responsibilities

• Partner closely with investigators and internal stakeholders to drive patient accrual.
• Identify key opinion leaders and cultivate a network of experts for key Alnylam disease areas.
• Conduct and implement a comprehensive disease awareness tactical plan within the respective geography.
• Collaborate with health care professionals to identify opportunities for the development of algorithms and guidelines to facilitate early diagnosis.
• Provide in-depth drug and disease state information to health care providers in the respective geography.
• Serve as an educational resource to healthcare providers on disease state concepts, including providing effective presentations to groups, and participating in 1:1s discussions.
• Serve as a liaison to health care professionals and professional organizations and disease state advocacy groups. Support the efforts of patient support groups and educational foundations.
• Communicate medical insights and feedback gathered from scientific exchange and relevant information to define, update and support medical affairs strategies.
• Conduct discussions with external investigators to identify potential research gaps.
• Identify and facilitate opportunities for data generation activities through investigator-initiated research (IIS), Registry, and Medical Affairs-sponsored studies for research that is aligned with Alnylam’s strategic focus.
• Serve as a liaison between key corporate functional areas and healthcare providers who express interest in conducting investigator-initiated studies, to facilitate review and consideration of research proposals.
• Provide medical and scientific input into the planning and execution of advisory boards and work with physician experts to review speaker presentations and provide additional medical background where requested.
• Develop and conduct external and internal training and continuing education.
• Contribute to Alnylam's achievement of company objectives for pre-approved/approved products.
  
  

Qualifications

• Bachelor's degree and MSc and/or PhD in medical/biomedical/pharmaceutical related area
• 3+ years of experience as MSL is preferred
• Previous experience in Neurology and/or Hepatology and/or Nephrology is desired, not mandatory
• Able to travel at least 70% of the time, including the ability to travel overnight and occasionally during weekends, if required
• Fluent in Portuguese and Advanced in English
• Preferably based in North East/Central West of Brazil: Brasília, Salvador, Recife or Fortaleza
  
  

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.